Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review

References

• Ogston A. Micrococcus poisoning. J Anat Physiol. 1882;17:24–58.
   PubMedGoogle Scholar
• Classics in infectious diseases. “On abscesses”. Alexander Ogston (1844–1929). Rev Infect Dis. 1984;6:122–128.
   PubMedGoogle Scholar
• Skinner D, Keefer CS. Significance of bacteremia caused by Staphylococcus aureus: a study of one hundred and twenty-two cases and a review of the literature concerned with experimental infection in animals. Arch Intern Med (Chic). 1941;68:851–875.
   Google Scholar
• Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167:834–839.
   PubMedGoogle Scholar
• Federspiel JJ, Stearns SC, Peppercorn AF, et al. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med. 2012;172:363–365.
   PubMedGoogle Scholar
• Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–1239.
   PubMed Web of Science ®Google Scholar
• Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–473.
   PubMed Web of Science ®Google Scholar
• Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025–1035.
   PubMed Web of Science ®Google Scholar
• Miro JM, Anguera I, Cabell CH, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41:507–514.
   PubMed Web of Science ®Google Scholar
• DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin N Am. 2009;23:17–34.
   PubMed Web of Science ®Google Scholar
• Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis. 2009;48 (Suppl 4):S231–S237.
   PubMed Web of Science ®Google Scholar
• Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis. 1998;26:1179–1181.
   PubMed Web of Science ®Google Scholar
• Stryjewski ME, Corey GR. Methicillin-resistant Staphylococcus aureus: an evolving pathogen. Clin Infect Dis. 2014;58 (Suppl 1):S10–S19.
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532.
   PubMed Web of Science ®Google Scholar
• Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis. 2011;11:208–222.
   PubMed Web of Science ®Google Scholar
• Holland TL, Arnold C, Fowler VG. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014;312:1330–1341.
   PubMed Web of Science ®Google Scholar
• Proctor RA. Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis. 2012;54:1179–1186.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317.
   PubMed Web of Science ®Google Scholar
• Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect. 2013;19:492–500.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Gregson DB, Vanderkooi OG, et al. The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000–2006. Pediatr Infect Dis J. 2009;28:114–117.
   PubMed Web of Science ®Google Scholar
• Henderson KL, Johnson AP, Muller-Pebody B, et al. The changing aetiology of paediatric bacteraemia in England and Wales, 1998–2007. J Med Microbiol. 2010;59:213–219.
   PubMed Web of Science ®Google Scholar
• Steckelberg JM, Melton LJ, Ilstrup DM, et al. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990;88:582–588.
   PubMed Web of Science ®Google Scholar
• Laupland KB. Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Crit Care. 2004;8:R431–R436.
   PubMed Web of Science ®Google Scholar
• Laupland KB. Defining the epidemiology of bloodstream infections: the ‘gold standard’ of population-based assessment. Epidemiol Infect. 2013;141:2149–2157.
   PubMed Web of Science ®Google Scholar
• Lyytikäinen O, Ruotsalainen E, Järvinen A, et al. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995–2001. Eur J Clin Microbiol Infect Dis. 2005;24:399–404.
   PubMed Web of Science ®Google Scholar
• Huggan PJ, Wells JE, Browne M, et al. Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J. 2010;40:117–125.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis. 2008;198:336–343.
   PubMed Web of Science ®Google Scholar
• Mejer N, Westh H, Schønheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis. 2012;12:260.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Lyytikäinen O, Søgaard M, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19:465–471.
   PubMed Web of Science ®Google Scholar
• Benfield T, Espersen F, Frimodt-Møller N, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007;13:257–263.
   PubMed Web of Science ®Google Scholar
• Hill PC, Birch M, Chambers S, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97–103.
   PubMed Web of Science ®Google Scholar
• Allard C, Carignan A, Bergevin M, et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991–2005. Clin Microbiol Infect. 2008;14:421–428.
   PubMed Web of Science ®Google Scholar
• El Atrouni WI, Knoll BM, Lahr BD, et al. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis. 2009;49:e130–e138.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Gudlaugsson O, Kristinsson KG, et al. Staphylococcus aureus bacteraemia in Iceland, 1995–2008: changing incidence and mortality. Clin Microbiol Infect. 2011;17:513–518.
   PubMed Web of Science ®Google Scholar
• Blomfeldt A, Eskesen AN, Aamot HV, et al. Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality. Eur J Clin Microbiol Infect Dis. 2016;35:803–813.
   PubMed Web of Science ®Google Scholar
• Frederiksen MS, Espersen F, Frimodt MN, et al. Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. Pediatr Infect Dis J. 2007;26:398–405.
   PubMed Web of Science ®Google Scholar
• Hill PC, Wong CG, Voss LM, et al. Prospective study of 125 cases of Staphylococcus aureus bacteremia in children in New Zealand. Pediatr Infect Dis J. 2001;20:868–873.
   PubMed Web of Science ®Google Scholar
• Vanderkooi OG, Gregson D, Kellner JD, et al. Staphylococcus aureus bloodstream infections in children: a population-based assessment. Paediatr Child Health. 2011;16:276–280.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Gudlaugsson O, Kristinsson KG, et al. Low mortality of Staphylococcus aureus bacteremia in Icelandic children - Nationwide study on incidence and outcome. Pediatr Infect Dis J. 2015;34:140–144.
   PubMed Web of Science ®Google Scholar
• Frimodt-Møller N, Espersen F, Skinhøj P, et al. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect. 1997;3:297–305.
   PubMedGoogle Scholar
• Morgan M, Salmon R, Keppie N, et al. All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): the first year's results. J Hosp Infect. 1999;41:173–179.
   PubMed Web of Science ®Google Scholar
• Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis. 2001;184:1029–1034.
   PubMed Web of Science ®Google Scholar
• McDonald P, Mitchell E, Johnson H, et al. MRSA bacteraemia: North/South Study of MRSA in Ireland 1999. J Hosp Infect. 2002;52:288–291.
   PubMed Web of Science ®Google Scholar
• Griffiths C, Lamagni TL, Crowcroft NS, et al. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993–2002. Health Stat Q. 2004;(21):15–22.
   Google Scholar
• Jacobsson G, Dashti S, Wahlberg T, et al. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007;39:6–13.
   PubMed Web of Science ®Google Scholar
• Nielsen SL, Pedersen C, Jensen TG, et al. Decreasing incidence rates of bacteremia: a 9-year population-based study. J Infect. 2014;69:51–59.
   PubMed Web of Science ®Google Scholar
• Mehl A, Åsvold BO, Lydersen S, et al. Burden of bloodstream infection in an area of Mid-Norway 2002–2013: a prospective population-based observational study. BMC Infect Dis. 2017;17:205.
   PubMed Web of Science ®Google Scholar
• McMullan BJ, Bowen A, Blyth CC, et al. Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand children. JAMA Pediatr. 2016;170:979–986.
   PubMed Web of Science ®Google Scholar
• Cobos-Carrascosa E, Soler-Palacín P, Nieves Larrosa M, et al. Staphylococcus aureus bacteremia in children: changes during eighteen years. Pediatr Infect Dis J. 2015;34:1329–1334.
   PubMed Web of Science ®Google Scholar
• Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
   PubMed Web of Science ®Google Scholar
• Abernethy J, Sharland M, Johnson AP, et al. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ? J Med Microbiol. 2017;66:737–743.
   PubMed Web of Science ®Google Scholar
• Fitzgerald SF, O'Gorman J, Morris-Downes MM, et al. A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect. 2011;79:218–221.
   PubMed Web of Science ®Google Scholar
• Wang IK, Chang YC, Liang CC, et al. Bacteremia in hemodialysis and peritoneal dialysis patients. Intern Med. 2012;51:1015–1021.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Church DL, Mucenski M, et al. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003;187:1452–1459.
   PubMed Web of Science ®Google Scholar
• Smit J, Søgaard M, Schønheyder HC, et al. Diabetes and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case-control study. Eur J Endocrinol. 2016;174:631–639.
   PubMed Web of Science ®Google Scholar
• Hansen MU, Gotland N, Mejer N, et al. Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study. Infect Dis (Lond). 2017;49:689–697.
   PubMed Web of Science ®Google Scholar
• Larsen MV, Harboe ZB, Ladelund S, et al. Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study. HIV Med. 2012;13:45–53.
   PubMed Web of Science ®Google Scholar
• Spijkerman IJ, van Ameijden EJ, Mientjes GH, et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–1154.
   PubMed Web of Science ®Google Scholar
• Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis. 1974;129:725–727.
   PubMed Web of Science ®Google Scholar
• Craven DE, Rixinger AI, Goularte TA, et al. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a “shooting gallery”. Am J Med. 1986;80:770–776.
   PubMed Web of Science ®Google Scholar
• Fagan RP, Edwards JR, Park BJ, et al. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990–2010. Infect Control Hosp Epidemiol. 2013;34:893–899.
   PubMed Web of Science ®Google Scholar
• Burton DC, Edwards JR, Horan TC, et al. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA. 2009;301:727–736.
   PubMed Web of Science ®Google Scholar
• Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–1361.
   PubMed Web of Science ®Google Scholar
• Huggan PJ, Murdoch DR, Gallagher K, et al. Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteraemia. J Hosp Infect. 2008;69:345–349.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Thalme A, Kristjansson M, et al. Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience. Clin Microbiol Infect. 2015;21:772–778.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Kristjansson M, Kristinsson KG, et al. Staphylococcus aureus bacteraemia–nationwide assessment of treatment adequacy and outcome. J Infect. 2011;62:339–346.
   PubMed Web of Science ®Google Scholar
• Murdoch F, Danial J, Morris AK, et al. The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in adults. J Hosp Infect. 2017;97:133–139.
   PubMed Web of Science ®Google Scholar
• Jensen AG, Wachmann CH, Espersen F, et al. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002;162:25–32.
   PubMedGoogle Scholar
• Fätkenheuer G, Preuss M, Salzberger B, et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2004;23:157–162.
   PubMed Web of Science ®Google Scholar
• Burke RE, Halpern MS, Baron EJ, et al. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome. Infect Control Hosp Epidemiol. 2009;30:636–644.
   PubMed Web of Science ®Google Scholar
• Forsblom E, Ruotsalainen E, Mölkänen T, et al. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia. J Hosp Infect. 2011;78:102–107.
   PubMed Web of Science ®Google Scholar
• Le Moing V, Alla F, Doco-Lecompte T, et al. Staphylococcus aureus bloodstream infection and endocarditis – a prospective cohort study. PLoS One. 2015;10:e0127385.
   PubMed Web of Science ®Google Scholar
• Suryati BA, Watson M. Staphylococcus aureus bacteraemia in children: a 5-year retrospective review. J Paediatr Child Health. 2002;38:290–294.
   PubMed Web of Science ®Google Scholar
• Barrado L, Brañas P, Rojo P, et al. Molecular epidemiology of Staphylococcus aureus bacteremia in children, Spain: low risk of methicillin resistance. J Infect. 2014;68:195–198.
   PubMed Web of Science ®Google Scholar
• Murdoch F, Danial J, Morris AK, et al. The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in children. J Hosp Infect. 2017;97:127–132.
   PubMed Web of Science ®Google Scholar
• Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–797.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Tabak YP, Killian AD, et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med. 2006;34:2588–2595.
   PubMed Web of Science ®Google Scholar
• Lenz R, Leal JR, Church DL, et al. The distinct category of healthcare associated bloodstream infections. BMC Infect Dis. 2012;12:85.
   PubMed Web of Science ®Google Scholar
• Paulsen J, Mehl A, Askim Å, et al. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study. BMC Infect Dis. 2015;15:116.
   PubMed Web of Science ®Google Scholar
• Naidoo R, Nuttall J, Whitelaw A, et al. Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children's hospital in Cape Town, South Africa. PLoS One. 2013;8:e78396.
   PubMed Web of Science ®Google Scholar
• Chang FY, MacDonald BB, Peacock JEJ, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82:322–332.
   PubMed Web of Science ®Google Scholar
• Fowler VG, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066–2072.
   PubMed Web of Science ®Google Scholar
• Holden E, Bashir A, Das I, et al. Staphylococcus aureus bacteraemia in a UK tertiary referral centre: a 'transoesophageal echocardiogram for all' policy. J Antimicrob Chemother. 2014;69:1960–1965.
   PubMed Web of Science ®Google Scholar
• Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68:242–251.
   PubMed Web of Science ®Google Scholar
• Fowler VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30:1072–1078.
   PubMed Web of Science ®Google Scholar
• Rasmussen RV, Høst U, Arpi M, et al. Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr. 2011;12:414–420.
   PubMed Web of Science ®Google Scholar
• Incani A, Hair C, Purnell P, et al. Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis. Eur J Clin Microbiol Infect Dis. 2013;32:1003–1008.
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Mathur G, Kelly J, et al. The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia. J Infect. 2005;51:218–221.
   PubMed Web of Science ®Google Scholar
• Joseph JP, Meddows TR, Webster DP, et al. Prioritizing echocardiography in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2013;68:444–449.
   PubMed Web of Science ®Google Scholar
• Kaasch AJ, Fowler VGJ, Rieg S, et al. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis. 2011;53:1–9.
   PubMed Web of Science ®Google Scholar
• Bai AD, Agarwal A, Steinberg M, et al. Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2017. pii: S1198-743X:30236–30237 [Epub ahead of print].
   Web of Science ®Google Scholar
• van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25:362–386.
   PubMed Web of Science ®Google Scholar
• Roediger JC, Outhred AC, Shadbolt B, et al. Paediatric Staphylococcus aureus bacteraemia: a single-centre retrospective cohort. J Paediatr Child Health. 2017;53:180–186.
   PubMed Web of Science ®Google Scholar
• Le J, Dam Q, Tran T, et al. Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period. Epidemiol Infect. 2017;145:2631–2639.
   PubMed Web of Science ®Google Scholar
• Valente AM, Jain R, Scheurer M, et al. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics. 2005;115:e15–e19.
   PubMed Web of Science ®Google Scholar
• Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638.
   PubMed Web of Science ®Google Scholar
• Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–209.
   PubMed Web of Science ®Google Scholar
• Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614–617.
   PubMed Web of Science ®Google Scholar
• Thuny F, Grisoli D, Collart F, et al. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965–975.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–3128.
   PubMed Web of Science ®Google Scholar
• Thalme A, Westling K, Julander I. In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes. Scand J Infect Dis. 2007;39:197–204.
   PubMed Web of Science ®Google Scholar
• Slipczuk L, Codolosa JN, Davila CD, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8:e82665.
   PubMed Web of Science ®Google Scholar
• Muñoz P, Kestler M, De Alarcon A, et al. Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort study. Medicine (Baltimore). 2015;94:e1816.
   PubMed Web of Science ®Google Scholar
• Mathew J, Addai T, Anand A, et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155:1641–1648.
   PubMedGoogle Scholar
• Hogevik H, Olaison L, Andersson R, et al. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore). 1995;74:324–339.
   PubMed Web of Science ®Google Scholar
• Scudeller L, Badano L, Crapis M, et al. Population-based surveillance of infectious endocarditis in an Italian region. Arch Intern Med. 2009;169:1720–1723.
   PubMedGoogle Scholar
• Fowler VG, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–3021.
   PubMed Web of Science ®Google Scholar
• Fernández Guerrero ML, González López JJ, Goyenechea A, et al. Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore). 2009;88:1–22.
   PubMed Web of Science ®Google Scholar
• Hsu RB, Lin FY. Methicillin resistance and risk factors for embolism in Staphylococcus aureus infective endocarditis. Infect Control Hosp Epidemiol. 2007;28:860–866.
   PubMed Web of Science ®Google Scholar
• Remadi JP, Habib G, Nadji G, et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg. 2007;83:1295–1302.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Thalme A, Weiland O. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: experience from a Swedish referral hospital. Medicine (Baltimore). 2016;95:e5617.
   PubMed Web of Science ®Google Scholar
• Røder BL, Wandall DA, Frimodt-Møller N, et al. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med. 1999;159:462–469.
   PubMed Web of Science ®Google Scholar
• Cervera C, Castañeda X, de la Maria CG, et al. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis. Clin Infect Dis. 2014;58:1668–1675.
   PubMed Web of Science ®Google Scholar
• Abdallah L, Remadi JP, Habib G, et al. Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis. Arch Cardiovasc Dis. 2016;109:260–267.
   PubMed Web of Science ®Google Scholar
• Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017–1028.
   PubMed Web of Science ®Google Scholar
• Scheidegger C, Zimmerli W. Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis. 1989;11:486–493.
   PubMedGoogle Scholar
• Tuazon CU, Sheagren JN. Staphlococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med. 1975;82:788–790.
   PubMed Web of Science ®Google Scholar
• Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev. 1963;27:56–71.
   PubMedGoogle Scholar
• Noble WC, Valkenburg HA, Wolters CH. Carriage of Staphylococcus aureus in random samples of a normal population. J Hyg (Lond). 1967;65:567–573.
   PubMedGoogle Scholar
• Nilsson P, Ripa T. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol. 2006;44:3334–3339.
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–762.
   PubMed Web of Science ®Google Scholar
• Lowy FD, Miller M. New methods to investigate infectious disease transmission and pathogenesis – Staphylococcus aureus disease in drug users. Lancet Infect Dis. 2002;2:605–612.
   PubMed Web of Science ®Google Scholar
• Quagliarello B, Cespedes C, Miller M, et al. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis. 2002;35:671–677.
   PubMed Web of Science ®Google Scholar
• Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363:139–149.
   PubMed Web of Science ®Google Scholar
• McDonald JR. Acute infective endocarditis. Infect Dis Clin N Am. 2009;23:643–664.
   PubMed Web of Science ®Google Scholar
• Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368:1425–1433.
   PubMed Web of Science ®Google Scholar
• Faber M, Frimodt-Møller N, Espersen F, et al. Staphylococcus aureus endocarditis in Danish intravenous drug users: high proportion of left-sided endocarditis. Scand J Infect Dis. 1995;27:483–487.
   PubMed Web of Science ®Google Scholar
• Ruotsalainen E, Sammalkorpi K, Laine J, et al. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis. 2006;6:137.
   PubMed Web of Science ®Google Scholar
• Wilson LE, Thomas DL, Astemborski J, et al. Prospective study of infective endocarditis among injection drug users. J Infect Dis. 2002;185:1761–1766.
   PubMed Web of Science ®Google Scholar
• Cherubin CE, Baden M, Kavaler F, et al. Infective endocarditis in narcotic addicts. Ann Intern Med. 1968;69:1091–1098.
   PubMed Web of Science ®Google Scholar
• Banks T, Fletcher R, Ali N. Infective endocarditis in heroin addicts. Am J Med. 1973;55:444–451.
   PubMed Web of Science ®Google Scholar
• Tung MK, Light M, Giri R, et al. Evolving epidemiology of injecting drug use-associated infective endocarditis: a regional centre experience. Drug Alcohol Rev. 2015;34:412–417.
   PubMed Web of Science ®Google Scholar
• Cooper HL, Brady JE, Ciccarone D, et al. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis. 2007;45:1200–1203.
   PubMed Web of Science ®Google Scholar
• Statens offentliga utredningar (SOU) 2011:35. Bättre insatser vid missbruk och beroende. Stockholm: Statens offentliga utredningar; 2011.
   Google Scholar
• Chai LY, Khare CB, Chua A, et al. Buprenorphine diversion: a possible reason for increased incidence of infective endocarditis among injection drug users? The Singapore experience. Clin Infect Dis. 2008;46:953–955.
   PubMed Web of Science ®Google Scholar
• Kaech C, Elzi L, Sendi P, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12:345–352.
   PubMed Web of Science ®Google Scholar
• Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ. 2006;333:281–284.
   PubMedGoogle Scholar
• Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 1998;19:32–37.
   PubMed Web of Science ®Google Scholar
• Ammerlaan H, Seifert H, Harbarth S, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009;49:997–1005.
   PubMed Web of Science ®Google Scholar
• Yahav D, Shaked H, Goldberg E, et al. Time trends in Staphylococcus aureus bacteremia, 1988–2010, in a tertiary center with high methicillin resistance rates. Infection. 2017;45:51–57.
   PubMed Web of Science ®Google Scholar
• Gray JW. A 7-year study of bloodstream infections in an English children's hospital. Eur J Pediatr. 2004;163:530–535.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Elaldi N, Balkan İ, et al. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann Clin Microbiol Antimicrob. 2016;15:7.
   PubMed Web of Science ®Google Scholar
• Rieg S, Joost I, Weisz V, et al. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia—a post hoc analysis in 964 prospectively evaluated patients. Clin Microbiol Infect. 2016;23:406.e1–406.e8.
   Web of Science ®Google Scholar
• Yahav D, Yassin S, Shaked H, et al. Risk factors for long-term mortality of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2016;35:785–790.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim KH, Kim HB, et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008;52:192–197.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Trecarichi EM, et al. Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality. PLoS One. 2017;12:e0170236.
   PubMed Web of Science ®Google Scholar
• Smit J, López-Cortés LE, Kaasch AJ, et al. Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study. Clin Microbiol Infect. 2017;23:27–32.
   PubMed Web of Science ®Google Scholar
• Soriano A, Martínez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2000;30:368–373.
   PubMed Web of Science ®Google Scholar
• Mansur N, Hazzan R, Paul M, et al. Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med. 2012;9:463–470.
   PubMedGoogle Scholar
• Holmes NE, Turnidge JD, Munckhof WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis. 2011;204:340–347.
   PubMed Web of Science ®Google Scholar
• Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation – a study of 521 patients in Germany. J Infect. 2009;59:232–239.
   PubMed Web of Science ®Google Scholar
• Turnidge JD, Kotsanas D, Munckhof W, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust. 2009;191:368–373.
   PubMed Web of Science ®Google Scholar
• Perez-Jorge EV, Burdette SD, Markert RJ, et al. Staphylococcus aureus bacteremia (SAB) with associated S. aureus bacteriuria (SABU) as a predictor of complications and mortality. J Hosp Med. 2010;5:208–211.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Kristjansson M, Kristinsson KG, et al. Clinical significance of Staphylococcus aureus bacteriuria in a nationwide study of adults with S. aureus bacteraemia. J Infect. 2012;64:41–46.
   PubMed Web of Science ®Google Scholar
• Chihara S, Popovich KJ, Weinstein RA, et al. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study. BMC Infect Dis. 2010;10:225.
   PubMed Web of Science ®Google Scholar
• Lodise TP, McKinnon PS, Swiderski L, et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418–1423.
   PubMed Web of Science ®Google Scholar
• Robinson JO, Pearson JC, Christiansen KJ, et al. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis. 2009;28:353–361.
   PubMed Web of Science ®Google Scholar
• Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2010;65:2658–2665.
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–59.
   PubMed Web of Science ®Google Scholar
• Shurland S, Zhan M, Bradham DD, et al. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273–279.
   PubMed Web of Science ®Google Scholar
• Jokinen E, Laine J, Huttunen R, et al. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains. Infect Dis (Lond). 2017;49:493–500.
   PubMed Web of Science ®Google Scholar
• Castón JJ, González-Gasca F, Porras L, et al. High vancomycin minimum inhibitory concentration is associated with poor outcome in patients with methicillin-susceptible Staphylococcus aureus bacteremia regardless of treatment. Scand J Infect Dis. 2014;46:783–786.
   PubMed Web of Science ®Google Scholar
• Bouiller K, Gbaguidi-Haore H, Hocquet D, et al. Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality. Clin Microbiol Infect. 2016;22:451–455.
   PubMed Web of Science ®Google Scholar
• Kempker RR, Farley MM, Ladson JL, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. J Infect. 2010;61:372–381.
   PubMed Web of Science ®Google Scholar
• Giannitsioti E, Damoraki G, Rokkas C, et al. Impact of haplotypes of TNF in the natural course of infective endocarditis. Clin Microbiol Infect. 2014;20:459–464.
   PubMed Web of Science ®Google Scholar
• Lee BK, Crossley K, Gerding DN. The association between Staphylococcus aureus bacteremia and bacteriuria. Am J Med. 1978;65:303–306.
   PubMed Web of Science ®Google Scholar
• Pulcini C, Matta M, Mondain V, et al. Concomitant Staphylococcus aureus bacteriuria is associated with complicated S. aureus bacteremia. J Infect. 2009;59:240–246.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Samra Z, Konigsberger H, et al. Long-term survival following bacteremia or fungemia. JAMA. 1995;274:807–812.
   PubMed Web of Science ®Google Scholar
• Hanses F, Spaeth C, Ehrenstein BP, et al. Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection. 2010;38:465–470.
   PubMed Web of Science ®Google Scholar
• Gotland N, Uhre ML, Mejer N, et al. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study. J Infect. 2016;73:346–357.
   PubMed Web of Science ®Google Scholar
• Kaasch AJ, Rieg S, Neumann S, et al. Measuring mortality in Staphylococcus aureus bloodstream infections: are 3 months of follow-up enough? Infection. 2011;39:281–282.
   PubMed Web of Science ®Google Scholar
• Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38:1276–1283.
   PubMed Web of Science ®Google Scholar
• Nielsen SL, Lassen AT, Gradel KO, et al. Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study. J Infect. 2015;70:111–126.
   PubMed Web of Science ®Google Scholar
• Storgaard M, Hallas J, Gahrn-Hansen B, et al. Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock. Scand J Infect Dis. 2013;45:577–583.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Svenson LW, Gregson DB, et al. Long-term mortality associated with community-onset bloodstream infection. Infection. 2011;39:405–410.
   PubMed Web of Science ®Google Scholar
• Espersen F, Frimodt-Møller N. Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med. 1986;146:1118–1121.
   PubMed Web of Science ®Google Scholar
• Watanakunakorn C. Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med. 1994;154:2330–2335.
   PubMedGoogle Scholar
• Rasmussen RV, Snygg-Martin U, Olaison L, et al. One-year mortality in coagulase-negative Staphylococcus and Staphylococcus aureus infective endocarditis. Scand J Infect Dis. 2009;41:456–461.
   PubMed Web of Science ®Google Scholar
• Lauridsen TK, Park L, Tong SY, et al. Echocardiographic findings predict in-hospital and 1-year mortality in left-sided native valve Staphylococcus aureus endocarditis: analysis from the international collaboration on endocarditis-prospective echo cohort study. Circ Cardiovasc Imaging. 2015;8:e003397.
   PubMed Web of Science ®Google Scholar
• Julander I. Unfavourable prognostic factors in Staphylococcus aureus septicemia and endocarditis. Scand J Infect Dis. 1985;17:179–187.
   PubMed Web of Science ®Google Scholar
• Cabell C, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90–94.
   PubMedGoogle Scholar
• Kiefer T, Park L, Tribouilloy C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239–2247.
   PubMed Web of Science ®Google Scholar
• Miró JM, del Río A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21:167–184.
   PubMedGoogle Scholar
• Tuazon CU, Cardella TA, Sheagren JN. Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med. 1975;135:1555–1561.
   PubMedGoogle Scholar
• Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis. 1986;8:374–396.
   PubMedGoogle Scholar
• Chambers HF, Korzeniowski OM, Sande MA. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore). 1983;62:170–177.
   PubMed Web of Science ®Google Scholar
• Grumann D, Ruotsalainen E, Kolata J, et al. Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia. Clin Vaccine Immunol. 2011;18:487–493.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–e434.
   Google Scholar
• García-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272–2284.
   PubMed Web of Science ®Google Scholar
• Snygg-Martin U, Gustafsson L, Rosengren L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47:23–30.
   PubMed Web of Science ®Google Scholar
• Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation. 2009;120:585–591.
   PubMed Web of Science ®Google Scholar
• Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010;152:497–504.
   PubMed Web of Science ®Google Scholar
• Iung B, Tubiana S, Klein I, et al. Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study. Stroke. 2013;44:3056–3062.
   PubMed Web of Science ®Google Scholar
• Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J. 2001;142:75–80.
   PubMed Web of Science ®Google Scholar
• Durante Mangoni E, Adinolfi LE, Tripodi MF, et al. Risk factors for “major” embolic events in hospitalized patients with infective endocarditis. Am Heart J. 2003;146:311–316.
   PubMed Web of Science ®Google Scholar
• Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001;37:1069–1076.
   PubMed Web of Science ®Google Scholar
• Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict clinical complications: a meta-analysis. J Am Soc Echocardiogr. 1997;10:562–568.
   PubMed Web of Science ®Google Scholar
• Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168:2095–2103.
   PubMedGoogle Scholar
• Fowler VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478–486.
   PubMed Web of Science ®Google Scholar
• Johnson LB, Almoujahed MO, Ilg K, et al. Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse. Scand J Infect Dis. 2003;35:782–789.
   PubMed Web of Science ®Google Scholar
• Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004–2007). Int J Antimicrob Agents. 2009;34:121–130.
   PubMed Web of Science ®Google Scholar
• Jones RN, Ross JE, Bell JM, et al. Zyvox annual appraisal of potency and spectrum program: linezolid surveillance program results for 2008. Diagn Microbiol Infect Dis. 2009;65:404–413.
   PubMed Web of Science ®Google Scholar
• Sabater S, Moreno R. Staphylococcus aureus bacteremia in Castellón General Hospital (2001–2005). Rev Esp Quimioter. 2008;21:217–223.
   PubMed Web of Science ®Google Scholar
• Fortún J, Navas E, Martínez-Beltrán J, et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis. 2001;33:120–125.
   PubMed Web of Science ®Google Scholar
• Calain P, Krause KH, Vaudaux P, et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis. 1987;155:187–191.
   PubMed Web of Science ®Google Scholar
• Chang FY, Peacock JEJ, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82:333–339.
   PubMed Web of Science ®Google Scholar
• Khatib R, Johnson LB, Sharma M, et al. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time. Scand J Infect Dis. 2009;41:4–9.
   PubMed Web of Science ®Google Scholar
• Rehm SJ, Tice A. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin Infect Dis. 2010;51 Suppl 2:S176–S182.
   PubMed Web of Science ®Google Scholar
• Limbago BM, Kallen AJ, Zhu W, et al. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States. J Clin Microbiol. 2014;52:998–1002.
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Vos MC, Boelens HA, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56:321–325.
   PubMed Web of Science ®Google Scholar
• Skov R, Gudlaugsson O, Hardardottir H, et al. Proposal for common Nordic epidemiological terms and definitions for methicillin-resistant Staphylococcus aureus (MRSA). Scand J Infect Dis. 2008;40:495–502.
   PubMed Web of Science ®Google Scholar
• Jokinen E, Laine J, Huttunen R, et al. Combined interventions are effective in MRSA control. Infect Dis (Lond). 2015;47:801–807.
   PubMed Web of Science ®Google Scholar
• Frimodt-Møller N, Espersen F, Rosdahl VT. Antibiotic treatment of Staphylococcus aureus endocarditis. A review of 119 cases. Acta Med Scand. 1987;222:175–182.
   PubMedGoogle Scholar
• Blyth CC, Darragh H, Whelan A, et al. Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia. Intern Med J. 2002;32:224–232.
   PubMed Web of Science ®Google Scholar
• Mitchell DH, Howden BP. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med J. 2005;35 (Suppl 2):S17–S24.
   PubMed Web of Science ®Google Scholar
• Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–2413.
   PubMed Web of Science ®Google Scholar
• Corey GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis. 2009;48 Suppl 4:S254–S259.
   PubMed Web of Science ®Google Scholar
• Chong YP, Moon SM, Bang KM, et al. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study. Antimicrob Agents Chemother. 2013;57:1150–1156.
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537–1541.
   PubMed Web of Science ®Google Scholar
• Osmon S, Ward S, Fraser VJ, et al. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest. 2004;125:607–616.
   PubMed Web of Science ®Google Scholar
• Verhagen DW, van der Meer JT, Hamming T, et al. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study. Scand J Infect Dis. 2003;35:459–463.
   PubMed Web of Science ®Google Scholar
• Kaasch AJ, Fätkenheuer G, Prinz-Langenohl R, et al. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial. Trials. 2015;16:450.
   PubMedGoogle Scholar
• Chirouze C, Alla F, Fowler VGJ, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin Infect Dis. 2015;60:741–749.
   PubMed Web of Science ®Google Scholar
• Rabkin DG, Mokadam NA, Miller DW, et al. Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg. 2012;93:51–57.
   PubMed Web of Science ®Google Scholar